COST-UTILITY ANALYSIS OF DONEPEZIL FOR THE TREATMENT OF ALZHEIMER'S DISEASE IN THAILAND

被引：0
|
作者：
Permsuwan, U. [1 ]
Niwatananun, W. [1 ]
Pimkrai, A. [2 ]
机构：
[1] Chiang Mai Univ, Chiang Mai 50000, Thailand
[2] Chiang Mai Neurol Hosp, Chiang Mai, Thailand
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.268
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A648 / A648
页数：1
相关论文
共 50 条
  • [41] Long-term cost-effectiveness of donepezil for the treatment of Alzheimer’s disease
    Stefan J. Teipel
    Michael Ewers
    Veronika Reisig
    Bernd Schweikert
    Harald Hampel
    Michael Happich
    European Archives of Psychiatry and Clinical Neuroscience, 2007, 257 : 330 - 336
  • [42] The cost-utility of exelon patch in the management of patients with moderate Alzheimer's disease in the United Kingdom
    Brennan, A.
    Nagy, B.
    Brandtmuller, A.
    Thomas, S. K.
    Sullivan, S. D.
    Akehurst, R.
    VALUE IN HEALTH, 2007, 10 (06) : A384 - A384
  • [43] Long-term cost-effectiveness of donepezil for the treatment of Alzheimer's disease
    Teipel, Stefan J.
    Ewers, Michael
    Reisig, Veronika
    Schweikert, Bernd
    Hampel, Harald
    Happich, Michael
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2007, 257 (06) : 330 - 336
  • [44] Cost-Utility of the Rivastigmine Transdermal Patch in the Management of Patients with Moderate Alzheimer's Disease in the US
    Nagy, Balazs
    Brennan, Alan
    Brandtmueller, Agnes
    Thomas, Simu K.
    Sullivan, Sean D.
    Akehurst, Ron
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2008, 16 (03): : A106 - A107
  • [45] A COST-UTILITY ANALYSIS OF TREATMENT OPTIONS FOR GALLSTONE DISEASE - METHODOLOGICAL ISSUES AND RESULTS
    COOK, J
    RICHARDSON, J
    STREET, A
    HEALTH ECONOMICS, 1994, 3 (03) : 157 - 168
  • [46] COST-UTILITY ANALYSIS FOR HAEMATE-P IN THE TREATMENT OF VON WILLEBRAND DISEASE
    Linden, S.
    Valera, Mendez P.
    Tomic, R.
    Vandebrouck, T.
    Vella, V. A.
    Barrientos, Vidal L.
    Yan, S.
    Wilson, M.
    VALUE IN HEALTH, 2023, 26 (12) : S193 - S193
  • [47] COST-EFFECTIVENESS OF DONEPEZIL IN ALZHEIMER'S DISEASE IN SWEDEN
    Mesterton, J.
    By, A.
    Sandelin, R.
    Jonsson, L.
    VALUE IN HEALTH, 2009, 12 (07) : A369 - A369
  • [48] A synthesis of cost-utility analysis literature in infectious disease
    Stone, PW
    Schackman, BR
    Neukermans, CP
    Olchanski, N
    Greenberg, D
    Rosen, AB
    Neumann, PJ
    LANCET INFECTIOUS DISEASES, 2005, 5 (06): : 383 - 391
  • [49] Cost-Utility Analysis of Biologic Disease-Modifying Antirheumatic Drugs for Patients With Psoriatic Arthritis in Thailand
    Dilokthornsakul, Piyameth
    Sawangjit, Ratree
    Osiri, Manathip
    Chiowchanwisawakit, Praveena
    Louthrenoo, Worawit
    Permsuwan, Unchalee
    VALUE IN HEALTH REGIONAL ISSUES, 2023, 34 : 40 - 47
  • [50] Cost-Utility Analysis of Dapagliflozin as an Add-on to Standard of Care for Patients with Chronic Kidney Disease in Thailand
    Vareesangthip, Kriengsak
    Deerochanawong, Chaicharn
    Thongsuk, Dittaya
    Pojchaijongdee, Nuch
    Permsuwan, Unchalee
    ADVANCES IN THERAPY, 2022, 39 (03) : 1279 - 1292
12345